跳转至内容

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN

59353-U21

Supelco

Discovery® C8 (5 µm) HPLC Columns

L × I.D. 15 cm × 2.1 mm, HPLC Column

登录查看公司和协议定价

选择尺寸

1 EA
¥7,908.02

¥7,908.02


请联系客服了解存货情况


选择尺寸

变更视图
1 EA
¥7,908.02

About This Item

UNSPSC代码:
41115700
eCl@ss:
32110501
NACRES:
SB.52

¥7,908.02


请联系客服了解存货情况

产品名称

Discovery ® C8 HPLC 色谱柱, 5 μm particle size, L × I.D. 15 cm × 2.1 mm

物料

stainless steel column

质量水平

Agency

suitable for USP L7

产品线

Discovery®

特点

endcapped

制造商/商品名称

Discovery®

包装

1 ea of

标记范围

7.5% Carbon loading

参数

≤70 °C temp. range
400 bar pressure (5801 psi)

正在寻找类似产品? 访问 产品对比指南

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
59354U3059353U4059353U
matrix active group

C8 (octyl) phase

matrix active group

C8 (octyl) phase

matrix active group

C8 (octyl) phase

matrix active group

C8 (octyl) phase

particle size

5 μm

particle size

5 μm

particle size

5 μm

particle size

5 μm

matrix

silica gel, high purity, spherical base material, fully porous particle

matrix

silica gel, high purity, spherical base material, fully porous particle

matrix

silica gel, high purity, spherical base material, fully porous particle

matrix

silica gel, high purity, spherical base material, fully porous particle

product line

Discovery®

product line

Discovery®

product line

Discovery®

product line

Discovery®

agency

suitable for USP L7

agency

suitable for USP L7

agency

suitable for USP L7

agency

suitable for USP L7

特点和优势

  • 优良的重现性。
  • 分析强疏水性化合物时比 C18 柱快
  • 稳定性好、低流失,适用于 LC-MS 分析
  • 分析碱性和酸性化合物均可获得良好峰形
  • 可兼容低有机溶剂/高含水量的流动相

法律信息

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hugo M Botelho et al.
Scientific reports, 5, 9038-9038 (2015-03-13)
Plasma membrane proteins are essential molecules in the cell which mediate interactions with the exterior milieu, thus representing key drug targets for present pharma. Not surprisingly, protein traffic disorders include a large range of diseases sharing the common mechanism of
M Q Zhang et al.
Die Pharmazie, 46(10), 687-700 (1991-10-01)
The rapid growth in the quinolone research changed the whole face of the previous SAR concepts. So far structural modifications at all positions of the quinolone nucleus except the 4-oxo group have successfully lead to the discovery of potent antimicrobial
G L Bundy et al.
The Journal of biological chemistry, 261(2), 747-751 (1986-01-15)
The gorgonian coral Pseudoplexaura porosa contains a lipoxygenase capable of converting exogenous arachidonic acid into (8R)-8-hydroperoxy-5,9,11,14-eicosatetraenoic acid. The (8R)- (or 8-L-) configuration in this product, opposite to that observed in previously reported 8-lipoxygenase products, was determined unambiguously by comparison of
Simeon Grazio et al.
Clinical and experimental rheumatology, 31(5), 665-671 (2013-06-07)
Using proteomic approach in this study, we sought to identify proteins with heparin affinity associated with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and non-inflammatory arthritis (NIA). Plasma samples from adult RA, PsA and NIA patients, 20 of each, were collected.
Scott C Bell et al.
Pharmacology & therapeutics, 145, 19-34 (2014-06-17)
With the discovery of the CFTR gene in 1989, the search for therapies to improve the basic defects of cystic fibrosis (CF) commenced. Pharmacological manipulation provides the opportunity to enhance CF transmembrane conductance regulator (CFTR) protein synthesis and/or function. CFTR

相关内容

Discovery C18 and C8 HPLC Columns products offered

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持